Advertisement
Advertisement

AVXL

AVXL logo

Anavex Life Sciences

2.50
USD
Sponsored
-0.20
-7.41%
Jul 10, 15:59 UTC -4
Closed
exchange

After-Market

2.55

+0.05
+1.96%

AVXL Earnings Reports

Positive Surprise Ratio

AVXL beat 25 of 37 last estimates.

68%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.08
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
-50.00%

Anavex Life Sciences earnings per share and revenue

On May 07, 2026, AVXL reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.07 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.08 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Replimune Group, Inc.
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.72
Actual
-$0.76
Surprise
-4.52%
logo
Beyond Air, Inc. Common Stock
Report Date
Jun 26, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.63
Surprise
-9.00%
FAQ
For Q2 2026, Anavex Life Sciences reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 5 analysts, Anavex Life Sciences is expected to report EPS of -$0.08 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement